Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses

Completed · Phase 2 · Has a placebo group

Conditions studied: Common Cold

In brief

The purpose of this study is to evaluate the efficacy of 3804-250A in the prevention of the common cold. The study will also evaluate whether 3804-250A prevents rhinovirus infection, a virus that causes many common colds.

Key facts

Study ID

NCT00762476

Run by

The Dial Corporation

People needed

411

Starts

2008-08-01

Expected to finish

2008-11-01

Last updated by the study team

2012-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy normal
• good general health

You may not qualify if…

• pregnancy
• insulin dependent diabetes
• daily smoker
• skin disease on the hands/wrists
• immunological disorders
• occupation involving frequent handwashing
• common cold symptoms

Where it is running

• TKL Research, Inc. — Paramus, New Jersey, United States
• University of Virginia School of Medicine — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.